Altogether, in this study, we were able to characterize the prognostic and functional role of several kinesin family members of which KIF11 provided the most promising properties as a novel prognostic marker and therapeutic target, which may offer new treatment options for aggressive meningiomas. This evidence concerns the gene KIF11 and meningioma.